LIDOCAINE HYDROCHLORIDE INJECTIO. Key specifications include primary_container_type: VIAL, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, primary_container_content_quantity: 30.000 MILLILITERS, active_medicament_medicinal_strength: 1.000 PERCENTAGE, W/V LIDOCAINE HYDROCHLORIDE ACTIVE INGREDIENT, part_name_assigned_by_controlling_agency: LIDOCAINE-MPF 1% 30ML VIAL. This product is currently in active production with full OEM support.
This part is cataloged in the Federal Logistics Information System (FLIS) under NSN 6505-01-690-9147, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| special_features | LIDOCAINE (PF) 10 MG/ML (1%) INJECTION SOLUTION 30 ML, 25 VIALS/PG. SHOULD BE STORED AT 20 TO 25 C (68 TO 77 F) (SEE USP CONTROLLED ROOM TEMPERATURE). PROTECT FROM LIGHT. |
| primary_container_type | VIAL |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| primary_container_content_quantity | 30.000 MILLILITERS |
| active_medicament_medicinal_strength | 1.000 PERCENTAGE, W/V LIDOCAINE HYDROCHLORIDE ACTIVE INGREDIENT |
| part_name_assigned_by_controlling_agency | LIDOCAINE-MPF 1% 30ML VIAL |
| NSN | 6505-01-690-9147 |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| SPECIAL FEATURES | LIDOCAINE (PF) 10 MG/ML (1%) INJECTION SOLUTION 30 ML, 25 VIALS/PG. SHOULD BE STORED AT 20 TO 25 C (68 TO 77 F) (SEE USP CONTROLLED ROOM TEMPERATURE). PROTECT FROM LIGHT. |
| PRIMARY CONTAINER CONTENT QUANTITY | 30.000 MILLILITERS |
| PRIMARY CONTAINER TYPE | VIAL |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 1.000 PERCENTAGE, W/V LIDOCAINE HYDROCHLORIDE ACTIVE INGREDIENT |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | LIDOCAINE-MPF 1% 30ML VIAL |